Nationally Notifiable Infectious Diseases and Conditions, United States: Annual Tables

TABLE 2n. Annual reported cases of notifiable diseases, by region and reporting area, United States and U.S. Territories, excluding Non-U.S. Residents*, 2019
Data from some jurisdictions may be incomplete due to the coronavirus disease 2019 (COVID-19) pandemic. Please see Note #9 at the bottom of the table.
Reporting Area Rabies Rubella Rubella, congenital syndrome Salmonella Paratyphi infection § Salmonella Typhi infection 
Animal Human
U.S. Residents, excluding U.S. Territories 4,645 6 1 155 409
New England 361 20 27
Connecticut 41 8 9
Maine 109 1 1
Massachusetts 131 10 11
New Hampshire 34 5
Rhode Island 30 1 1
Vermont 16
Middle Atlantic 913 1 39 110
New Jersey 249 8 33
New York (excluding New York City) 391 8 32
New York City 24 1 16 36
Pennsylvania 249 7 9
East North Central 203 18 56
Illinois 54 6 31
Indiana 10 5 8
Michigan 59 4 10
Ohio 42 3 6
Wisconsin 38 1
West North Central 165 1 1 18
Iowa 8 2
Kansas 55
Minnesota 36 1 10
Missouri 24 1 4
Nebraska 21 2
North Dakota 5
South Dakota 16
South Atlantic 1,568 32 90
Delaware 9
District of Columbia 9 1
Florida 129 6 28
Georgia 222 9
Maryland 269 3 21
North Carolina 315 12
South Carolina 148 2
Virginia 385 12 27
West Virginia 82 1
East South Central 89 5 5
Alabama 50
Kentucky 13 4 1
Mississippi 3
Tennessee 23 1 4
West South Central 623 1 20 41
Arkansas 26 8 4
Louisiana 8 1
Oklahoma 24 1 1
Texas 565 11 36
Mountain 417 1 9 29
Arizona 138 1 7
Colorado 163 3 8
Idaho 15 2 1
Montana 18
Nevada 20 1 6
New Mexico 27 1
Utah 12 7
Wyoming 24 2
Pacific 306 3 11 33
Alaska 12 1 1
California 276 3
Hawaii 2
Oregon 9 1 4
Washington 9 9 26
U.S. Territories 45 6 4
American Samoa U
Commonwealth of Northern Mariana Islands
Guam
Puerto Rico 45 6 4
U.S. Virgin Islands
  • —: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
  • U: Unavailable — The data are unavailable.
  • * The 2019 annual tables exclude cases of nationally notifiable conditions and diseases among non-U.S. residents. As a result, data in Table 2 does not include a "Non-U.S. Resident" or "Total" row, that would have been included in the table had the data been stratified into the following four categories, based upon the "country of usual residence" (COUR) algorithm: U.S. Residents, excluding U.S. Territories; U.S. Territories; Non-US. Residents; and Total.Table 2 for the 2019 annual tables only includes the first two of these stratification categories.
  • † To calculate rates, use the populations provided in Table 8. Note that calculation of rates for the following conditions use population subsets presented in Table 8: Zika virus infection, congenital; Zika virus disease, congenital; Infant botulism; Congenital rubella syndrome; Perinatal Hepatitis B infection, Perinatal Hepatitis C infection, Haemophilus influenzae, invasive disease and Invasive pneumococcal disease, and Influenza associated pediatric mortality; see Table 8 (population reference table). Also see notes 3 and 7.
  • § Beginning in January 2019, cases began to be reported as Salmonella Paratyphi infection. In 2018, cases were reported as paratyphoid fever. Prior to 2018, cases of paratyphoid fever were considered salmonellosis.
  • ¶ Beginning in January 2019, cases began to be reported as Salmonella Typhi infection. In previous years, cases were reported as typhoid fever.